Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      EMEA/Climate change and why it matters to healthcare

      Climate change and why it matters to healthcare

      Climate change and why it matters to healthcare

      As the world’s most broadly based healthcare company, we have a duty to act

      It’s pretty clear that there’s a direct link between climate change and health: in fact, according to the World Health Organization, climate change is the single biggest health threat facing humanity[1]. It affects the social and environmental determinants of health, like clean air, safe drinking water, sufficient food and secure shelter. Extreme heat leads to heat-related illnesses and cardiovascular failure; environmental degradation leads to forced migration and the mental and physical health issues that come with it; rising sea levels affect water quality, which leads to diseases such a cholera and leptospirosis; and air pollution leads to Asthma and cardiovascular disease[2]. And on it goes. According to The Lancet, 77% of healthcare professionals believe climate change will cause harm to their patients.[3]

      Sobering facts. And they are, unfortunately, just the beginning. The direct cost to health, excluding costs in sectors such as agriculture and water and sanitation, is estimated to reach between USD 2-4 billion/year by 2030[4]. Between 2030 and 2050, climate change is expected to cause 250,000 additional deaths each year.[5]

      As a healthcare company, we believe that Johnson & Johnson exists to change the trajectory of health for humanity. Which means we need to play our part in looking after the health of the planet too. That’s why we partnered with Economist Impact on their webinar, Caring for the climate: The role of healthcare in driving climate action; to continue the conversation about the role of healthcare in driving climate action.

      Alongside it being the right thing to do, acting on climate change is also good business sense. According to the Harvard Business Review, companies that adopt environmental standards see a 16% increase in productivity[6]. It plays into recruitment too: taking a robust stance on the environment is key to attracting and retaining the best people – over half (53%) of the UK’s workforce say sustainability is an important factor in choosing a company to work for[7].

      So, what are we doing about it? Firstly, we’re decarbonising our operations and value chain, and creating more sustainable products and solutions. Building on more than two decades of climate action, our current climate goals are accelerating the transition to 100% renewable electricity and carbon neutrality in our global operations. We’re also engaging with our suppliers to help reduce upstream emissions. Secondly, we’re using our voice and our partnerships to promote change. As the world’s largest and most broadly based healthcare company, we can make a difference. Our progress will continue to be tracked via initiatives like the Health For Humanity goals[8], which are transparent, public-facing key performance indicators that show how well we’re doing when it comes to creating a sustainable future.

      Human health depends on protecting our planet. It’s a challenging, often alarming prospect, but also one that brings opportunities to change and innovate. I’ll discuss some of our green initiatives in future posts, from the granular – our new, plant-based packaging, say – to larger systemic innovation: the upgrading of our supply chain, for example, and our use of renewable electricity. All of these plans will help us become more sustainable, and shift us closer to our ultimate goal of creating a future where disease is a thing of the past.

      References

      [1]https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health [Last accessed April 2022]

      [2]https://www.cdc.gov/climateandhealth/effects/default.htm [Last accessed April 2022]

      [3]https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(21)00053-X/fulltext [Last accessed April 2022]

      [4]https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health [Last accessed April 2022]

      [5]https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health [Last accessed April 2022]

      [6]https://hbr.org/2016/10/the-comprehensive-business-case-for-sustainability#:~:text=Better%20morale%20and%20motivation%20translate,positively%20impacts%20turnover%20and%20recruitment. [Last accessed April 2022]

      [7]https://www.anthesisgroup.com/sustainability-vital-for-employee-attraction/ [Last accessed April 2022]

      [8]https://www.jnj.com/health-for-humanity-goals-2025 [Last accessed April 2022]

      Mark Hicken
      Mark Hicken
      Mark Hicken
      Mark Hicken is Vice President of Strategy for Europe, Middle East and Africa (EMEA) at Janssen. Mark leads a cross-functional team that drives Janssen’s continued growth across the region, in close collaboration with the local operating companies. He focuses on maintaining Janssen’s competitive edge by setting a shared direction across multiple functions, helping Janssen’s people realise their full potential, and resourcing them to deliver for patients across EMEA. Prior to this role, Mark led Janssen global strategy for Neuroscience where he oversaw the preparation and launch of new products and refreshed Janssen’s approach in this therapy area, broadening its footprint beyond psychiatry into neurological disorders. Beginning his career with Janssen in 1998 as a sales representative, Mark worked up through the organisation to become Managing Director for Janssen UK & Ireland from 2014 to 2019. During his tenure, he grew the UK business significantly and was a board member of the Association of British Pharmaceutical Industry (ABPI) and Vice-chair of the American Pharma Group. Mark holds a Postgraduate Diploma in Health Promotion from Manchester University and a BA (Hons) Sport & Recreation Studies from Staffordshire University